Medical Oncology

Doç. Dr. Ahmet Özveren

Doctor and researcher Acıbadem Kent Hastanesi (İzmir) İzmir
Gastrointestinal NeoplasmsPancreatic NeoplasmsBreast NeoplasmsObesityLung Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Gastrointestinal Neoplasms 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Pancreatic Neoplasms 3 publications
  • Breast Neoplasms 2 publications
  • Obesity 2 publications
  • Lung Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Yumurtalık (Over) Kanseri
  • Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
  • Baş Boyun Kanserleri
  • Jinekolojik Tümörler ve Kanserler (Rahim, Serviks, Yumurtalık/Over Kanseri vb.)
  • Karaciğer Kanseri
  • Meme Kanseri
  • Mide Kanseri
  • Pankreas Kanseri
  • Prostat Kanseri
  • Kolorektal Kanserler (Kolon ve Rektum Kanseri)
  • Akciğer Kanseri
  • Kolon (Kalın Bağırsak) Kanseri

CV

Education and experience

From source

Experience

  • 2023Acıbadem Sağlık Grubuacibadem.com.tr
  • 2017 - 2019Giresun Üniversitesi Giresun Prof. Dr. A. İlhan Özdemir Eğitim ve Araştırma Hastanesi / Tıbbi Onkoloji Uzmanıacibadem.com.tr
  • 2014 - 2017Ege Üniversitesi Tıp Fakültesi/ Onkoloji Yan Dal Asistanıacibadem.com.tr
  • 2013 - 2014Van Çaldıran Devlet Hastanesi / İç Hastalıklarıacibadem.com.tr
  • 2009 - 2013İzmir Tepecik Eğitim ve Araştırma Hastanesi / İç Hastalıkları Asistanıacibadem.com.tr
  • 2008 - 2009Amasya Toplum Sağlığı Merkezi / Pratisyen Hekimacibadem.com.tr

Education

  • 2017Ege Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2013İzmir Tepecik Eğitim ve Araştırma Hastanesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 2008Ege Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Kent Hastanesi (İzmir)acibadem.com.trFrom source
  • Area of workGastrointestinal NeoplasmsExtracted from 3 publications · Model version —From source
  • Publications42 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-6432-5432ORCIDFrom source
  • Last synchronised4 November 2026 21:08https://www.acibadem.com.tr/doktor/ahmet-ozveren/acibadem.com.tr

Scientific work

Publications on Gastrointestinal Neoplasms

42 publications

  1. Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

    Cancers, 2026

    DOI 10.3390/cancers18121979 PMID 42352512 Open-access full textSource: OpenAlex

  2. Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

    Cancers, 2026

    DOI 10.3390/cancers18142302 PMID 42512369 Open-access full textSource: ORCID

  3. Impact of oral nutritional support adherence on muscle strength, body composition, and general health status in gastrointestinal cancer patients: ONMUS study

    Nutrition, 2026

    DOI 10.1016/j.nut.2025.113029 PMID 41455457 1 citation (Europe PMC) Source: ORCID

  4. Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group

    International Journal of Cancer, 2025

    DOI 10.1002/ijc.70213 PMID 41147655 3 citations (Europe PMC) Source: OpenAlex

  5. Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study

    Discover Oncology, 2025

    DOI 10.1007/s12672-025-03886-1 PMID 41249604 Open-access full textSource: OpenAlex

  6. Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study

    Medicina, 2025

    DOI 10.3390/medicina61071230 PMID 40731859 Open-access full textSource: OpenAlex

  7. Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study

    Cancers, 2024

    DOI 10.3390/cancers17010046 PMID 39796675 9 citations (Europe PMC) Open-access full textSource: ORCID

  8. Alterations in muscle strength among patients with GI cancers receiving oral nutritional support as soon as malnutrition was detected: ONMUS study.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.3_suppl.741 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  9. The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-75293-5 PMID 39384975 1 citation (Europe PMC) Open-access full textSource: ORCID

  10. Is there a role for cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from unusual types of cancer?

    European Journal of Surgical Oncology, 2024

    DOI 10.1016/j.ejso.2023.107866 Source: OpenAlex

View all 42 publications